Feedback / Questions
BB-1701 - BlissBio, Eisai
Halaven (eribulin mesylate) - Eisai
E7386 - Eisai, PRISM Pharma
https://www.prnewswire.com/news-releases/eisai-accelerates-progress-in-oncology-research-with-new-data-at-esmo-congress-2024-including-first-interim-analysis-results-from-the-phase-3-leap-012-trial-302237387.html
Sep 4, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next